Literature DB >> 20948402

Surgical treatment of giant intracranial arteriovenous malformations.

Jizong Zhao1, Tao Yu, Shuo Wang, Yuanli Zhao, Wu Yang Yang.   

Abstract

BACKGROUND: The treatment of giant arteriovenous malformations (AVMs) remains a challenge in the neurosurgical field. Microsurgery is one of the most effective ways for eliminating giant cerebral AVMs.
OBJECTIVE: To review surgical outcomes in treating the disease, and form conclusions regarding the indications for and outcomes of surgical treatment in giant intracranial AVMs.
METHODS: We studied 40 consecutive cases of giant AVMs treated in Beijing Tiantan Hospital between 2000 and 2008. The radiologic and clinical features were analyzed. The Spetzler-Martin grading system was used to classify the patients. All patients were surgically treated, and the final outcomes of the patients were gathered for analysis.
RESULTS: The major presenting symptoms were seizures, headaches, hemorrhage, and neurological deficits. The mean AVM diameter was 6.3 cm. According to the Spetzler-Martin grading system, 5 patients had grade III lesions, 21 had grade IV lesions, and 14 had grade V lesions. Out of the total 40 patients, 31 (77.5%) demonstrated excellent or good outcome. Complications included hemiparalysis, aphasia, hemianopia, cranial nerve dysfunction, and seizures. After follow-up, 27 of 30 (90%) surviving patients presented normal function or minimal symptoms.
CONCLUSION: Presurgical evaluation of every candidate and treatment choice is the determining factor in therapy for giant AVMs. For giant cerebral AVMs located superficially or not involving critical components, a good outcome can be expected through surgical resection. The obliteration and recurrence rates were satisfying, and the complication rate was acceptable.

Entities:  

Mesh:

Year:  2010        PMID: 20948402     DOI: 10.1227/NEU.0b013e3181eda216

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  5 in total

1.  Bleeding source identification and treatment in brain arteriovenous malformations.

Authors:  N Mjoli; D Le Feuvre; A Taylor
Journal:  Interv Neuroradiol       Date:  2011-10-17       Impact factor: 1.610

2.  Hypofractionated stereotactic radiotherapy for large arteriovenous malformations.

Authors:  Huan-Chih Wang; Rachel J Chang; Furen Xiao
Journal:  Surg Neurol Int       Date:  2012-04-26

3.  Surgical Resection of a Progressive Giant Arteriovenous Malformation After 13-year Follow-Up.

Authors:  Chao Fu; Weidong Yu; Zheng Feng; Conghai Zhao; Donghui Xu; Dongyuan Li
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

4.  Functional MRI-guided microsurgery of intracranial arteriovenous malformations: study protocol for a randomised controlled trial.

Authors:  Bing Zhao; Yong Cao; Yuanli Zhao; Jun Wu; Shuo Wang
Journal:  BMJ Open       Date:  2014-10-23       Impact factor: 2.692

5.  Hypofractionated stereotactic radiotherapy for large or involving critical organs cerebral arteriovenous malformations.

Authors:  Sławomir Blamek; Dawid Larysz; Leszek Miszczyk; Adam Idasiak; Adam Rudnik; Rafał Tarnawski
Journal:  Radiol Oncol       Date:  2013-02-01       Impact factor: 2.991

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.